DB
Therapeutic Areas
Sensible Medical Innovations Pipeline
| Drug | Indication | Phase |
|---|---|---|
| ReDS™ System | Pulmonary congestion monitoring in heart failure and other fluid‑related conditions | Commercial |
Leadership Team at Sensible Medical Innovations
AL
Avi Ludomirski
CEO
AB
Aital Bergman
CFO
NH
Nahum Hai
COO
JD
John DeChellis
EVP Sales
SB
Shlomi Bergida
VP Product
NM
Nadav Mizrahi
VP R&D
RS
Ronit Shaanan
VP Quality Affairs
EG
Elad Gelbart
VP Clinical Affairs
WA
William Abraham
Advisory – Ohio State University
SA
Stefan Anker
Advisory – Charité University